Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic/Laparoscopic Esophagectomy for cT1b-3N0-1M0 Thoracic Esophageal Cancer
Sponsor: Chinese Academy of Medical Sciences
This observational or N/A phase trial investigates Esophageal Cancer and is currently ongoing. Chinese Academy of Medical Sciences leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Jan 2025 — Present [monthly]
Unknown
-
Sep 2024 — Jan 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status
-
Dec 2022 — Oct 2023 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences
- Fujian Cancer Hospital
- Harbin Medical University
- Hebei Medical University Fourth Hospital
- Henan Cancer Hospital
- Hunan Cancer Hospital
- Liaoning Cancer Hospital & Institute
- Peking University Cancer Hospital & Institute
- Shanghai Chest Hospital
- Shanghai Zhongshan Hospital
- Sichuan Cancer Hospital and Research Institute
- Sun Yat-sen University
- Tang-Du Hospital
- Zhejiang Cancer Hospital
For direct contact, visit the study record on ClinicalTrials.gov .